84 related articles for article (PubMed ID: 8017854)
1. Identification of the aromatase in the breast carcinoma cell lines T47D and MCF-7.
Sadekova SI; Tan L; Chow TY
Anticancer Res; 1994; 14(2A):507-11. PubMed ID: 8017854
[TBL] [Abstract][Full Text] [Related]
2. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
3. Effect of the progestagen Promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells.
Pasqualini JR; Maloche C; Maroni M; Chetrite G
Anticancer Res; 1994; 14(4A):1589-93. PubMed ID: 7979190
[TBL] [Abstract][Full Text] [Related]
4. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
[TBL] [Abstract][Full Text] [Related]
5. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas.
Di GH; Lu JS; Song CG; Li HC; Shen ZZ; Shao ZM
J Exp Clin Cancer Res; 2005 Dec; 24(4):601-7. PubMed ID: 16471323
[TBL] [Abstract][Full Text] [Related]
6. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
Kao YC; Okubo T; Sun XZ; Chen S
Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
[TBL] [Abstract][Full Text] [Related]
7. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
8. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
9. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells.
Zhou D; Zhou C; Chen S
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):273-80. PubMed ID: 9365201
[TBL] [Abstract][Full Text] [Related]
10. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
11. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of aromatase activity and expression in MCF-7 cells by the chemopreventive retinoid N-(4-hydroxy-phenyl)-retinamide.
Ciolino HP; Wang TT; Sathyamoorthy N
Br J Cancer; 2000 Aug; 83(3):333-7. PubMed ID: 10917548
[TBL] [Abstract][Full Text] [Related]
13. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
Ethier SP; Kokeny KE; Ridings JW; Dilts CA
Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
[TBL] [Abstract][Full Text] [Related]
14. Transient expression of the cytochrome P450 aromatase gene in elongating porcine blastocysts is correlated with uterine insulin-like growth factor levels during peri-implantation development.
Ko Y; Choi I; Green ML; Simmen FA; Simmen RC
Mol Reprod Dev; 1994 Jan; 37(1):1-11. PubMed ID: 8129925
[TBL] [Abstract][Full Text] [Related]
15. Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening.
Zhou DJ; Pompon D; Chen SA
Cancer Res; 1990 Nov; 50(21):6949-54. PubMed ID: 2208160
[TBL] [Abstract][Full Text] [Related]
16. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
Castles CG; Fuqua SA; Klotz DM; Hill SM
Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
[TBL] [Abstract][Full Text] [Related]
17. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.
Wang-Johanning F; Frost AR; Johanning GL; Khazaeli MB; LoBuglio AF; Shaw DR; Strong TV
Clin Cancer Res; 2001 Jun; 7(6):1553-60. PubMed ID: 11410490
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
[TBL] [Abstract][Full Text] [Related]
19. Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells.
Martínez-Campa C; González A; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ; Cos S
Breast Cancer Res Treat; 2005 Dec; 94(3):249-54. PubMed ID: 16244789
[TBL] [Abstract][Full Text] [Related]
20. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S
Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]